This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Learn about ligneous conjunctivitis, a rare and chronic eye condition. Discover its symptoms, underlying causes, and available treatment options.

Itchy eyes can be uncomfortable, even crazy-making, and many of us experience them at one time or another. If you’re ...

Paris: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment ...

Dupixent approved by FDA for bullous pemphigoid, offering a new option for adults with the rare autoimmune skin disease ...

The surge in cases is closely tied to seasonal weather patterns—intermittent rains, fluctuating temperatures, and high ...

Mental health treatment is on the rise among adults overall — up from 19.2% in 2019 to 21.6% in 2021. However, ...

The new branding showcases the Company's innovative vision for the future and mission to redefine the retina experience ...

Nektar Therapeutics said on Tuesday its lead drug candidate met the main goal of a mid-stage study testing the drug in eczema patients, sending its shares up by nearly 140%. In the 393-patient global ...